ATLAS / Macro Radar / Reporting / GLUE

Monte Rosa Therapeutics, Inc. (GLUE) reporting calendar

Monte Rosa Therapeutics, Inc. files periodic reports with the SEC as GLUE on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
17 Jul 2026 – 28 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-210358
10-K31 Dec 202517 Mar 202676 days0001193125-26-109360
10-Q30 Sep 20256 Nov 202537 days0001193125-25-268045
10-Q30 Jun 20257 Aug 202538 days0000950170-25-104550
10-Q31 Mar 20258 May 202538 days0000950170-25-066372
10-K31 Dec 202420 Mar 202579 days0000950170-25-042344
10-Q30 Sep 20247 Nov 202438 days0000950170-24-122780
10-Q30 Jun 20248 Aug 202439 days0000950170-24-093296
10-Q31 Mar 20249 May 202439 days0000950170-24-056288
10-K31 Dec 202314 Mar 202474 days0000950170-24-031150
10-Q30 Sep 20239 Nov 202340 days0000950170-23-061995
10-Q30 Jun 202310 Aug 202341 days0000950170-23-040959
10-Q31 Mar 202311 May 202341 days0000950170-23-021201
10-K31 Dec 202216 Mar 202375 days0000950170-23-008440
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024447
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016844
10-Q31 Mar 202211 May 202241 days0000950170-22-009324
10-K31 Dec 202129 Mar 202288 days0000950170-22-004927
10-Q30 Sep 202110 Nov 202141 days0000950170-21-004138
10-Q30 Jun 202112 Aug 202143 days0000950170-21-001372

Source: SEC EDGAR company submissions for CIK 0001826457. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.